• 26/03/2020

    Professor John Murray remembered

    We received the sad news that KNCV’s friend and Union hero Professor John Murray passed away of acute respiratory failure…

    Lees meer
  • 24/03/2020

    World TB Day: Together we fight TB and the Coronavirus

    Today – on World TB Day – KNCV Tuberculosis Foundation (KNCV) sends a special message of support to everyone worldwide…

    Lees meer
  • 20/02/2020

    Kitty van Weezenbeek appointed as WHO Director Surveillance, Prevention and Control of AMR

    As of 1 May 2020, the current director of KNCV Tuberculosis Foundation, Kitty van Weezenbeek, will be appointed Director Surveillance,…

    Lees meer
  • 20/02/2020

    PDPs show the value of purpose driven R&D

    KNCV Tuberculosis Foundation looks back at a stimulating dialogue and sharing of good practices during the Product Development Partnerships (PDPs)…

    Lees meer
  • 14/02/2020

    Exhibition TB Photovoices: We conquer TB and TB stigma

    KNCV presents the TB Photovoices exhibition ‘We conquer TB and TB stigma’. This exhibition can be seen in the Atrium…

    Lees meer
  • 28/01/2020

    SOS Stool method brings Xpert TB diagnosis closer to children

    Using stool samples to diagnose TB in children with Xpert is now recommended by the WHO. KNCV Tuberculosis Foundation is…

    Lees meer
  • 28/01/2020

    The story of Issayas

    On the outskirts of Addis Ababa in Ethiopia, toddler Issayas lives with his father and mother in a small weathered…

    Lees meer
  • 22/01/2020

    ASCENT announcement: Request for proposal

    The ASCENT project announces a Request for Proposals (RFP) for Provision of hosting services for the ASCENT Digital Adherence Platform.

    Lees meer
  • 13/01/2020

    ASCENT procurement announcement: Requests for quotation

    The ASCENT project has two requests for quotation (RFQ’s): 1. For printing of cardstock medication sleeves. 2. To facilitate incoming…

    Lees meer
  • 13/01/2020

    Resistant forms of TB: more patient-friendly treatment

    People suffering from resistant forms of tuberculosis (TB) can now be cured by more patient-friendly treatments. The World Health Organization…

    Lees meer
  • 12/01/2020

    TB Stigma Reduction Symposium

    INVITATION: Stigma and discrimination are recognized as some of the most commonly identified barriers to fight the Tuberculosis (TB) epidemic.

    Lees meer
  • 12/01/2020

    The story of Abdurahim

    Four-year-old Abdurahim from Kyrgyzstan is so small he looks half that age. He had spinal and intra-thoracic lymph node tuberculosis…

    Lees meer
  • 12/12/2019

    Start of a new era in fight against drug resistant TB

    WHO released a rapid communication on the treatment of drug resistant (DR) and extensively drug resistant (XDR) tuberculosis (TB). This…

    Lees meer
  • 20/11/2019

    7th European Advanced Course in Clinical Tuberculosis

    The 7th European Advanced Course in Clinical Tuberculosis (TB) offered an informative and interactive program with national and international speakers…

    Lees meer
  • 31/10/2019

    3HP regimen soon to be accessible in Malawi

    KNCV Tuberculosis Foundation Malawi welcomes the substantial reduction in the price of the anti-tuberculosis drug rifapentine, announced today at the…

    Lees meer

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.